Blue Circle Speciality Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-06-2024
- Paid Up Capital ₹ 0.50 M
as on 16-06-2024
- Company Age 38 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.64 Cr
as on 16-06-2024
- Revenue %
(FY 2023)
- Profit 23.34%
(FY 2023)
- Ebitda 26.98%
(FY 2023)
- Net Worth -0.33%
(FY 2023)
- Total Assets -0.91%
(FY 2023)
About Blue Circle Speciality Chemicals
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹1.64 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Archana Arora and Akshay Arora serve as directors at the Company.
- CIN/LLPIN
U24100MH1986PTC038735
- Company No.
038735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Blue Circle Speciality Chemicals?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Archana Arora | Director | 27-Apr-1990 | Current |
Akshay Arora | Director | 27-Apr-1990 | Current |
Financial Performance of Blue Circle Speciality Chemicals.
Blue Circle Speciality Chemicals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 23.34% increase in profit. The company's net worth dipped by a decrease of 0.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Blue Circle Speciality Chemicals?
In 2023, Blue Circle Speciality Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Chinar Chemicals Private LimitedActive 43 years 10 months
Archana Arora and Akshay Arora are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Citibank N.A. Creation Date: 01 Jun 2006 | ₹1.50 Cr | Satisfied |
Dombivli Nagri Sahakari Bank Ltd Creation Date: 28 Aug 1991 | ₹1.20 M | Satisfied |
Dombivli Nagri Sahakari Bank Ltd Creation Date: 14 Mar 1991 | ₹0.20 M | Satisfied |
How Many Employees Work at Blue Circle Speciality Chemicals?
Unlock and access historical data on people associated with Blue Circle Speciality Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blue Circle Speciality Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blue Circle Speciality Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.